.Pharmacolibrary.Drugs.ATC.G.G02CB06 .Pharmacolibrary.Drugs.ATC.G.G02CB06| name: | Terguride | |
| ATC code: | G02CB06 | route: | oral |
| compartments: | 1 | |
| dosage: | 1 | mg |
| volume of distribution: | 5 | L |
| clearance: | 15 | L/h |
| other parameters in model implementation | ||
Terguride is a synthetic ergoline derivative with partial dopamine D2 receptor agonist and antagonist activity. It was under investigation for treatment of hyperprolactinemia, Parkinson's disease, and other prolactin-related disorders, but it is not currently marketed or approved for therapeutic use.
Estimated pharmacokinetic parameters in healthy adults based on related ergoline derivatives, as no direct human PK studies or published reports for terguride could be identified.